Steris (STE) Capital Expenditures (2018 - 2026)

Steris' Capital Expenditures history runs 9 years deep, the most recent figure standing at $90.2 million for Q1 2026.

• On a quarterly basis, Capital Expenditures rose 27.22% year-over-year to $90.2 million in Q1 2026; TTM through Mar 2026 was $369.0 million, a 0.3% change from a year earlier, with the FY2026 full-year figure at $369.0 million, changed 0.3% from the prior year.
• Capital Expenditures slipped to $90.2 million in Q1 2026 per STE's latest filing, from $98.7 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $118.9 million in Q4 2023 and bottomed at $66.6 million in Q2 2023.
• The 5-year median for Capital Expenditures is $90.2 million (2026), against an average of $90.3 million.
• Across the five-year window, Capital Expenditures surged 105.57% in 2022 and plunged 42.55% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $91.8 million in 2022, then rose by 29.53% to $118.9 million in 2023, then slipped by 25.0% to $89.2 million in 2024, then rose by 10.65% to $98.7 million in 2025, then declined by 8.61% to $90.2 million in 2026.
• Per Business Quant, the three latest STE Capital Expenditures figures stand at $90.2 million (Q1 2026), $98.7 million (Q4 2025), and $86.5 million (Q3 2025).